Comparison between the dissolution profiles of prolonged-release ciprofloxacin tablets available in the Colombian market
Two 1,000 mg prolonged-release ciprofloxacin (CIP) tablets marketed in Colombia were compared for quality control tests and dissolution profile as established in the United States Pharmacopeia 42-NF 37 and the Food and Drug Administration guidance on dissolution testing. The dissolution profiles in...
- Autores:
-
De la Cruz Gómez, Andrés Vicente
- Tipo de recurso:
- Fecha de publicación:
- 2020
- Institución:
- Universidad del Atlántico
- Repositorio:
- Repositorio Uniatlantico
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.uniatlantico.edu.co:20.500.12834/874
- Acceso en línea:
- https://hdl.handle.net/20.500.12834/874
https://www.scopus.com/record/display.uri?eid=2-s2.0-85125908811&doi=10.7324%2fJAPS.2022.120322&origin=inward&txGid=a7dda39c1201a04b7536b78e6ca0b4d6
- Palabra clave:
- Ciprofloxacin
pharmaceutical equivalence
dissolution profiles
prolonged-release tablets
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc/4.0/